Aaronson NK. Quality of life assessment in clinical trials: methodologic issues.Controlled Clin Trials 1989;10: 195S-208S.
Spilker B, ed.Quality of Life Assessment in Clinical Trials. New York: Raven Press, 1990.
Johnson JR, Temple R. Food and Drug Administration requirements for approval of new anticancer drugs.Cancer Treat Rep 1985;69: 1155–1157.
Moinpour CM, Feigl P, Metch B, et al. Quality of life endpoints in cancer clinical trials: Review and recommendations.J Natl Cancer Inst 1989;81: 485–495.
Skeel RT. Quality of life assessment in cancer clinical trials—it's time to catch up.J Natl Cancer Inst 1989;81: 472–473.
Selby P, Robertson B. Measurement of quality of life in patients with cancer.Cancer Surv 1987;6: 521–543.
Martini CJ, McDowell I. Health status: Patient and physician judgments.Health Services Research 1976;11: 508–515.
Wartman SA, Morlock LL, Malitz Fe, et al. Impact of divergent evaluations by physicians and patients of patients' complaints.Public Health Rep 1983;98: 141–145.
Slevin ML, Plant H, Lynch D, et al. Who should measure quality of life, the doctor or the patient?Br J Cancer 1988;57: 109–112.
Aaronson NK, Bakker W, Stewart AL, et al. Multidimensional approach to the measurement of quality of life in lung cancer clinical trials. In: Aaronson NK and Beckman J, eds.The Quality of Life of Cancer Patients. New York: Raven Press, 1987: 63–82.
Cella DF, Tulsky DS. Measuring quality of life today: Methodologic aspects.Oncology 1990;4: 29–38.
Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In: Spilker B, ed.Quality of Life Assessment in Clinical Trials. New York: Raven Press, 1990: 11–24.
Kaplan RM, Anderson JP. The general health policy model: An integrated approach. In: Spilker B, ed.Quality of Life Assessment in Clinical Trials. New York: Raven Press, 1990: 131–149.
Patrick DL, Ericson P. What constitutes quality of life? Concepts and dimensions.Clin Nutr 1988;7: 53–63.
Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life.Med Care 1989;27 (Suppl): S217–S232.
American Cancer Society.Cancer Facts and Figures—1990. Atlanta, Georgia: American Cancer Society, 1990.
National Cancer Institute: Surveillance, Epidemiology and End Results Program (SEER).Annual Cancer Statistics Review, November, 1984.
National Center for Health Statistics, 1949–1951 to 1979–81.
Mor V. Cancer patients' quality of life over the disease course: Lessons from the real world.J Chronic Dis 1987;40: 535–544.
Schmale AH, Morrow GR, Schmitt MH, et al. Well-being of cancer survivors.Psychosom Med 1983;45: 163–169.
Rieker PP, Fitzgerald EM, Kalish LA, et al. Psychosocial factors, curvative therapies, and behavioral outcomes: A comparison of testis cancer survivors and a control group of healthy men.Cancer 1989;64: 2399–2407.
Goldhirsch A, Gelber RD, Simes RJ, et al. For the Ludwig Breast Cancer Study Group. Costs and benefits of adjuvant therapy in breast cancer: A quality-adjusted survival analysis.J Clin Oncol 1989;7: 36–44.
Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population.Med Care 1988;26: 724–735.
Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.JAMA 1989;262: 907–913.
Shag CAC, Ganz PA, Heinrich RL. Cancer Rehabilitation Evaluation System—short form (CARES): A cancer-specific rehabilitation and quality of life instrument.Cancer 1991;68: 1406–1413.
Schag CAC, Heinrich RL. Development of a comprehensive quality of life measurement tool: CARES.Oncology 1990;4: 135–138.
Ganz PA, Schag CAC, Cheng H. Assessing the quality of life—A study in newly diagnosed breast cancer patients.J Clin Epidemiol 1990;43: 75–86.
Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: The Functional Living Index—Cancer: Development and validation.J Clin Oncol 1984;2: 472–483.
Schipper H, Levitt M. Measuring quality of life: Risks and benefits.Cancer Treat Rep 1985;69: 1115–1123.
Aaronson NK, Bullinger M, Ahmedzai S. A modular approach to quality-of-life assessment in cancer clinical trials.Recent Results in Cancer Res 1988;111: 231–249.
Levine MN, Guyatt HG, Gent M, et al. Quality of life in Stage II breast cancer: An instrument for clinical trials.J Clin Oncol 1988;6: 1798–1810.
Derogatis LR. The Psychosocial Adjustment to Illness Scale (PAIS).J. Psychosom Res 1986;30: 77–91.
Derogatis LR, Lopez M.PAIS & PAIS-SR: Administration, scoring and procedures manual—I. Baltimore: Clinical Psychometric Research, 1983.
McCorkle R, Young KJ. Development of a symptom distress scale.Cancer Nurs 1978;1: 373–378.
McCorkle R, Benoliel JQ. Symptom distress, current concerns and mood disturbances after diagnosis of life-threatening disease.Soc Sci Med 1983;17: 431–438.
McCorkle R, Benoliel JQ, Donaldson G, et al. A randomized clinical trial of home nursing care for lung cancer patients.Cancer 1989;64: 1375–1382.
McCorkle R. The measurement of symptom distress.Semin Oncol Nurs 1987;3: 248–256.
Young KJ, Longman AJ. Quality of life and persons with melanoma: A pilot study.Cancer Nurs 1983;6: 219–225.
deHaas JCJM, Welvaart K. Quality of life after breast cancer surgery.J Surg Oncol 1985;28: 123–125.
deHaas JCJM, van Oosrom MA, Welvaart K. The effect of radical and conserving surgery on the quality of life of early breast cancer patients.Eur J Surg Oncol 1986;12: 337–342.
deHaas JCJM, Raatgever JW, van der Burg MEL, et al. Evaluation of the quality of life of patients with advanced ovarian cancer treated with combination therapy. In: Aaronson NK, Beckman J, eds.The Quality of Life of Cancer Patients. New York: Raven Press, 1987; 215–226.
deHaas JCJM, van Knippenberg FCE. Quality of life of cancer patients. Review of the literature. In Aaronson NK, Beckmann J, eds.The Quality of Life of Cancer Patients. New York: Raven Press, 1987; 167–182.